{"product":{"id":8651172839586,"title":"Tirzepatide – 10mg","body_html":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003edual GIP and GLP-1 receptor agonist\u003c\/strong\u003e — a single molecule that activates two incretin pathways at once. In peptide research this dual mechanism has drawn intense interest for its effects on appetite signaling, insulin response and \u003cstrong\u003ebody-weight regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 72-week \u003cstrong\u003eSURMOUNT-1\u003c\/strong\u003e trial, participants on the 15 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 20.9%\u003c\/strong\u003e, versus 3.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e57%\u003c\/strong\u003e of that group lost a fifth or more of their body weight, and \u003cstrong\u003e91%\u003c\/strong\u003e lost at least 5%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eHead-to-head data reinforce the signal: in \u003cstrong\u003eSURPASS-2\u003c\/strong\u003e, tirzepatide produced greater weight loss than semaglutide — up to \u003cstrong\u003e5.5 kg more\u003c\/strong\u003e at the top dose — while lowering HbA1c by \u003cstrong\u003e2.30 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2107519\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e. Its dual-receptor design is widely cited as why it outperforms single-pathway GLP-1 agonists\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/oby.23612\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the tirzepatide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","vendor":"Prime Lab Peptides - USA","product_type":"Peptides","created_at":"2025-04-18T09:36:32-04:00","handle":"tirzepatide-10mg","updated_at":"2026-10-02T03:42:36-04:00","published_at":null,"template_suffix":"tirzepatide-10mg","published_scope":"global","tags":"In stock","variants":[{"id":45436979216546,"product_id":8651172839586,"title":"Default Title","price":"100.00","sku":"T10","position":1,"compare_at_price":"150.00","fulfillment_service":"manual","inventory_management":"shopify","option1":"Default Title","option2":null,"option3":null,"created_at":"2025-04-18T09:36:32-04:00","updated_at":"2026-10-02T03:42:36-04:00","taxable":false,"barcode":"","grams":15,"image_id":null,"weight":15.0,"weight_unit":"g","requires_shipping":true,"quantity_rule":{"min":1,"max":null,"increment":1},"price_currency":"USD","compare_at_price_currency":"USD","quantity_price_breaks":[]}],"options":[{"id":null,"product_id":8651172839586,"name":"Title","position":1,"values":["Default Title"]}],"images":[{"id":33087723765922,"product_id":8651172839586,"position":1,"created_at":"2025-04-18T09:36:32-04:00","updated_at":"2026-10-02T03:42:36-04:00","alt":"Tirzepatide – 10mg","width":3000,"height":3000,"src":"https:\/\/primelabpeptides.com\/wp-content\/themes\/primelab\/media.php?f=files\/Tirzepatide10mg001.png","variant_ids":[]},{"id":34761505341602,"product_id":8651172839586,"position":2,"created_at":"2025-04-18T09:36:32-04:00","updated_at":"2026-10-02T03:42:36-04:00","alt":"Certificate of Analysis — Tirzepatide 10mg — lot 094927982TIRZ — 99.87% purity — Freedom Diagnostics, 2\/3\/2026","width":791,"height":1024,"src":"https:\/\/primelabpeptides.com\/wp-content\/themes\/primelab\/media.php?f=files\/1770442555067-2c38224a-2782-4b03-996b-b4baae946880_1.png","variant_ids":[]}],"image":{"id":33087723765922,"product_id":8651172839586,"position":1,"created_at":"2025-04-18T09:36:32-04:00","updated_at":"2026-10-02T03:42:36-04:00","alt":"Tirzepatide – 10mg","width":3000,"height":3000,"src":"https:\/\/primelabpeptides.com\/wp-content\/themes\/primelab\/media.php?f=files\/Tirzepatide10mg001.png","variant_ids":[]}}}